Cromos Pharma

As we approach the end of the year, the integration of AI in clinical trials is revolutionizing drug development with groundbreaking innovations. From enhancing efficiency to enabling personalized treatments, these advancements are shaping the future of clinical research.? ? Key Highlights: - AI-generated digital twins streamline trials with fewer patients.? - Revolutionary AI tools accelerate heart failure screening.? - Organ-on-a-Chip combined with AI enhances drug evaluation.? - Protocol AI reduces trial setup time by 35 percent.? ? Read more: https://lnkd.in/e4QNXaJy #AI #ClinicalTrials #DigitalTwins #DrugDevelopment #Innovation #CromosPharma

? Cromos Pharma is currently seeking a Senior Clinical Research Associate for our team. ? Location: Bulgaria ? For additional details, kindly explore our website: https://lnkd.in/evSeAVEV ? If you're prepared to embark on your career with Cromos Pharma, please submit your CV to [email protected] ? #hiring #cromospharma #clinicaltrials

As Lung Cancer Awareness Month highlights the global burden of the disease, its impact remains grave, with approximately 1.8 million lives lost each year. However, recent advancements in cancer research offer hope: a groundbreaking combination therapy of amivantamab and lazertinib has demonstrated a significant improvement for patients with advanced non-small cell lung cancer (NSCLC). This innovative approach extends progression-free survival far beyond standard options, signaling a potential shift in the treatment of this aggressive cancer type. ? Read more in the article to learn about this breakthrough:https://lnkd.in/eQRQEHpp ? #LungCancerAwareness #CancerResearch #InnovationInCare #LungCancerTreatment #CromosPharma

World Diabetes Day: Diabetes impacts over 537 million people worldwide, including 38 million in the US and 60 million in Europe. Of those diagnosed, an overwhelming 90-95% have Type 2 diabetes. For many, managing Type 2 diabetes begins with metformin, but this alone is often insufficient. ? Fortunately, advanced treatments like GLP-1 agonists and SGLT2 inhibitors help control blood sugar, improve heart health, and manage weight. In our article, we dive into the key differences between GLP-1 and SGLT2 to help you find the right treatment. ? ?Discover how these medications are making a difference in diabetes care:https://lnkd.in/egD6VgPC ? ?#WorldDiabetesDay #Diabetes #GLP1 #SGLT2 #CromosPharma

In the November edition of Cromos Pharma's Newsletter, we delve into the latest advances in clinical research and healthcare: ? – EU Clinical Trials Regulation: Monika David discusses sponsor challenges and opportunities in adapting to new streamlined processes; ? – FDA Approves Hympavzi for Hemophilia; ? – HIV-Positive Kidney Transplantation; ? And much more. Explore the full newsletter here: https://lnkd.in/ebRkTbmB ? #ClinicalResearch #CromosPharma #ClinicalTrials ?#MedicalBreakthroughs

We are excited to announce that Cromos Pharma will be attending the 66th ASH Annual Meeting & Exposition, the largest and most comprehensive event in the field of classical and malignant hematology, taking place December 7-10, 2024, in San Diego, CA. This prestigious event gathers thousands of professionals from across the globe. ? Our CEO, Vlad Bogin, MD, FACP, looks forward to engaging with industry experts, clinicians, and researchers, exploring new trends and developments in hematology research and treatment. With hundreds of sessions highlighting cutting-edge advancements, the ASH meeting offers unparalleled opportunities for networking and collaboration. ? To schedule a meeting with Dr. Bogin, please contact us at [email protected] #ASH2024 #hematology #clinicalresearch #CRO #CromosPharma ?

A recent study reveals that placing defibrillator pads on the chest and back (anterior-posterior) more than doubles survival chances in out-of-hospital cardiac arrests. This simple yet powerful adjustment could transform emergency cardiac care and save countless lives. Read more in the article: https://lnkd.in/eenW8Gw9 #CromosPharma #OHCA #Defibrillation #CardiacCare #LifeSavingResearch

A major milestone in diabetes treatment: Chinese researchers have achieved insulin independence for over a year in a patient with type 1 diabetes using stem cell therapy. This breakthrough represents a potential shift from symptom management to a curative approach, bringing renewed hope to millions affected by this chronic condition. ? Read the full article for more insights:https://lnkd.in/et-MGrzr ? #DiabetesResearch #StemCellTherapy #Type1Diabetes #MedicalInnovation #ClinicalTrials #CromosPharma

?? Happy Halloween 2024! ? Cromos Pharma sends spooky wishes to our wonderful team, partners, clients, and friends. May your Halloween be filled with fun and treats! ? Have a night of thrilling adventures and sweet surprises. Happy trick-or-treating! #HappyHalloween2024 #CromosPharma #ThrillingTreats #TeamCromos ?

Cromos Pharma is currently seeking a Head of Therapeutic Strategy and Proposals for our team. Location: Central and Eastern Europe For additional details, kindly explore our website: https://lnkd.in/dgBUGgRE If you're prepared to embark on your career with Cromos Pharma, please submit your CV to [email protected] #hiring #cromospharma #clinicaltrials